Application Information

This drug has been submitted to the FDA under the reference 022117/001.

Names and composition

"SAPHRIS" is the commercial name of a drug composed of ASENAPINE MALEATE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
022117/001 SAPHRIS ASENAPINE MALEATE TABLET/SUBLINGUAL EQ 5MG BASE
022117/002 SAPHRIS ASENAPINE MALEATE TABLET/SUBLINGUAL EQ 10MG BASE
022117/003 SAPHRIS ASENAPINE MALEATE TABLET/SUBLINGUAL EQ 2.5 BASE

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
022117/001 SAPHRIS ASENAPINE MALEATE TABLET/SUBLINGUAL EQ 5MG BASE
022117/002 SAPHRIS ASENAPINE MALEATE TABLET/SUBLINGUAL EQ 10MG BASE
022117/003 SAPHRIS ASENAPINE MALEATE TABLET/SUBLINGUAL EQ 2.5 BASE

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved